Dna X (SONM) Receivables (2018 - 2026)

Dna X has reported Receivables for 9 years, with the latest figure at $57000.0 in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 99.5% year-over-year to $57000.0; the trailing twelve-month figure through Mar 2026 stood at $57000.0 (down 99.5% YoY), and the FY2024 full-year result was $4.5 million, down 82.79% from the prior year.
• Receivables for Q1 2026 stood at $57000.0, down from $13.3 million in the prior quarter.
• The five-year high for Receivables was $32.0 million in Q3 2023, with the low at $57000.0 in Q1 2026.
• Historically, Receivables has averaged $15.0 million across 5 years, with a median of $12.3 million in 2025.
• Annual changes were most pronounced in 2023 — Receivables surged 267.39% — and 2026, when it tumbled 99.5%.
• Dna X's Receivables stood at $24.7 million in 2022, then rose by 6.33% to $26.3 million in 2023, then slumped by 82.79% to $4.5 million in 2024, then surged by 195.11% to $13.3 million in 2025, then tumbled by 99.57% to $57000.0 in 2026.
• The last three Receivables figures came in at $57000.0 (Q1 2026), $13.3 million (Q3 2025), and $9.8 million (Q2 2025), per Business Quant data.